Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subcutaneous”

3,638 trials

Showing 20 of 3,638 results

Early research (Phase 1)Study completedNCT07787624
What this trial is testing

Phase 1 Clinical Study of MWN109 Injection in Healthy Chinese Volunteers

Who this might be right for
Healthy Volunteers
Shanghai Minwei Biotechnology Co., Ltd 48
Not applicableUnknownNCT01580462
What this trial is testing

The ADHERENCE Index - the Indicator of Effective Coping With the Requirements of the Disease of Children and Adolescents With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Institute of Mother and Child, Warsaw, Poland 200
Early research (Phase 1)Study completedNCT05028127
What this trial is testing

Evaluate the Relative Bioavailability and Tolerability of Bimekizumab in Healthy Subjects

Who this might be right for
Healthy Volunteers
UCB Celltech 12
Large-scale testing (Phase 3)Study completedNCT03399370
What this trial is testing

Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol

Who this might be right for
ASCVDElevated Cholesterol
The Medicines Company 1,561
Testing effectiveness (Phase 2)Study completedNCT06102005
What this trial is testing

Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe Asthma

Who this might be right for
Asthma
Sanofi 685
Post-approval studies (Phase 4)Study completedNCT00277394
What this trial is testing

Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis

Who this might be right for
Deep Vein Thrombosis
LEO Pharma 541
Early research (Phase 1)Study completedNCT03376802
What this trial is testing

A Clinical Study to Investigate the Effect of SAR425899 on Energy Expenditure in Obese Subjects

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 24
Testing effectiveness (Phase 2)Study completedNCT00040586
What this trial is testing

Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2

Who this might be right for
Prostatic Neoplasms
BZL Biologics
Large-scale testing (Phase 3)Study completedNCT02504541
What this trial is testing

Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism

Who this might be right for
Hypogonadism
Antares Pharma Inc. 133
Early research (Phase 1)Looking for participantsNCT07366866
What this trial is testing

Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults.

Who this might be right for
Autoimmune Disease
Changchun GeneScience Pharmaceutical Co., Ltd. 48
Testing effectiveness (Phase 2)Study completedNCT06500429
What this trial is testing

Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist

Who this might be right for
Overweight and ObesityHealthy
Neurogastrx, Inc. 120
Large-scale testing (Phase 3)Study completedNCT01874145
What this trial is testing

Safety and Tolerability of Glatiramer Acetate

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 209
Early research (Phase 1)Study completedNCT00652288
What this trial is testing

Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs

Who this might be right for
Diabetes Mellitus, Type I
Yale University 36
Testing effectiveness (Phase 2)WithdrawnNCT00850161
What this trial is testing

Intranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous Insulin

Who this might be right for
Type 1 Diabetes Mellitus
CPEX Pharmaceuticals Inc.
Early research (Phase 1)Study completedNCT02583594
What this trial is testing

Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple Sclerosis

Who this might be right for
Progressive Multiple Sclerosis
Genzyme, a Sanofi Company 24
Not applicableStudy completedNCT00532766
What this trial is testing

Evaluating Pharmacokinetics and Pharmacodynamics of Jusline

Who this might be right for
Healthy
King Saud University 20
Early research (Phase 1)Study completedNCT07214766
What this trial is testing

Assess the Bioequivalence of Trastuzumab Via Different Subcutaneous Delivery Platforms in Healthy Male Participants

Who this might be right for
Healthy Participants
Genentech, Inc. 331
Large-scale testing (Phase 3)Active Not RecruitingNCT05409066
What this trial is testing

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma

Who this might be right for
Follicular Lymphoma (FL)
Genmab 549
Testing effectiveness (Phase 2)Study completedNCT01660295
What this trial is testing

Pharmacokinetics of Certoparin in Subjects With Renal Insufficiency and Healthy Subjects

Who this might be right for
Renal Insufficiency
Novartis Pharmaceuticals 32
Large-scale testing (Phase 3)Looking for participantsNCT07140939
What this trial is testing

Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat

Who this might be right for
Subcutaneous Fat
Caliway Biopharmaceuticals Co., Ltd. 320
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation